The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.BI.

The specificity of peptide binding to MHC molecules is defined by binding motifs composed of several relatively conserved anchor positions. The peptide binding motifs of murine MHC class II I-A molecules are functionally important but poorly characterized. Here we use peptide binding studies and isolation of naturally presented peptides to characterize the peptide binding motif of the MHC class II I-A molecule, RT1.BI, a molecule that is involved in experimental autoimmunity in the Lewis rat. We now report that, similar to other class II motifs, the RT1.BI motif consists of a nonamer sequence with four major anchor positions (P1, P4, P6 and P9). Residues at P4 and P9, rather than at P1, appeared to be particularly important for binding. Negatively charged residues were favored at P9, consistent with the presence of a serine at position 57 of the RT1.BI beta chain. This RT1.BI motif could be observed in the dominant autoantigenic T cell epitopes mapped previously in the Lewis rat. These results highlight a general similarity and some important differences in the organization of MHC class II peptide binding motifs. The reported RT1.BI motif should facilitate the prediction and design of T cell epitopes for the induction and control of experimental autoimmune diseases in Lewis rat models.

[1]  G. Nepom,et al.  Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. , 1996, Journal of immunology.

[2]  E. Thorsby,et al.  Identification of a putative motif for binding of peptides to HLA-DQ2. , 1996, International immunology.

[3]  R. Karr,et al.  Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Rammensee,et al.  Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules. , 1995, International immunology.

[5]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[6]  J. Drijfhout,et al.  Clip binds to HLA class II using methionine-based, allele-dependent motifs as well as allele-independent supermotifs. , 1995, Molecular immunology.

[7]  R. Karr,et al.  Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association , 1995, The Journal of experimental medicine.

[8]  H. Rammensee,et al.  Chemistry of peptides associated with MHC class I and class II molecules. , 1995, Current opinion in immunology.

[9]  A Sette,et al.  Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II , 1995, The Journal of experimental medicine.

[10]  V. Gnau,et al.  Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules , 1995, The Journal of experimental medicine.

[11]  L. Steinman,et al.  Escape from “horror autotoxicus”: Pathogenesis and treatment of autoimmune disease , 1995, Cell.

[12]  H. Mcdevitt,et al.  Binding of an invariant-chain peptide, CLIP, to I-A major histocompatibility complex class II molecules. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  小島 公一 Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia , 1995 .

[14]  Z. Nagy,et al.  Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.

[15]  H. Lassmann,et al.  Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia , 1994, The Journal of experimental medicine.

[16]  H. Rammensee,et al.  Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. , 1994, Journal of immunology.

[17]  W. Hickey,et al.  Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. The utility of a class II binding motif in selecting self-reactive peptides. , 1994, Journal of immunology.

[18]  W. Hickey,et al.  Identification of an N-terminally acetylated encephalitogenic epitope in myelin proteolipid apoprotein for the Lewis rat. , 1994, Journal of Immunology.

[19]  D. Zaller,et al.  Prediction of peptide affinity to HLA DRB1*0401. , 1994, International archives of allergy and immunology.

[20]  W. van Eden,et al.  CDR1 T-cell receptor beta-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Rothbard,et al.  Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. , 1994, Journal of immunology.

[22]  S. Buus,et al.  Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules , 1994, International immunology.

[23]  M. Davis,et al.  Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). , 1994, Journal of immunology.

[24]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[25]  C. Janeway,et al.  Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. , 1994, Journal of immunology.

[26]  I. Cohen,et al.  Autoimmune disease models : a guidebook , 1994 .

[27]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[28]  F. Sinigaglia,et al.  Identification of a motif for HLA-DR1 binding peptides using M13 display libraries , 1992, The Journal of experimental medicine.

[29]  H. Lassmann,et al.  Cell adhesion molecules of the immunoglobulin supergene family as tissue‐specific autoantigens: induction of experimental allergic neuritis (EAN) by PO protein‐specific T cell lines , 1992, European journal of immunology.

[30]  I. Cohen,et al.  Induction of experimental autoimmune encephalomyelitis by native myelin basic protein‐activated T lymphocyte lines , 1992, European journal of immunology.

[31]  G. Adamus,et al.  Specificity of T and B cell responses to bovine rhodopsin in Lewis rats. , 1991, Cellular immunology.

[32]  D. Wiley,et al.  Peptide binding to HLA‐DR1: a peptide with most residues substituted to alanine retains MHC binding. , 1990, The EMBO journal.

[33]  G. Flouret,et al.  The N- and C-terminal boundaries of myelin basic protein determinants required for encephalitogenic and proliferative responses of Lewis rat T cells , 1990, Journal of Neuroimmunology.

[34]  T. Olee,et al.  A T cell epitope for experimental allergic neuritis , 1988, Journal of Neuroimmunology.

[35]  J. Lindstrom,et al.  Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides. , 1988, Journal of immunology.

[36]  I. Cohen,et al.  Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis , 1988, Nature.

[37]  A Sette,et al.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides , 1987, Science.

[38]  I. Cohen,et al.  Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. , 1984, The Journal of clinical investigation.